申请人:Beecham Group Limited
公开号:US04385066A1
公开(公告)日:1983-05-24
Compounds of formula (II): ##STR1## or a pharmaceutically acceptable salt, lower alkyl or aralkyl ester or amide thereof, wherein R.sup.1 and R.sup.2, which may be the same or different, are each of a hydrogen atom or a methyl group, n is 1, 2 or 3, and Z is a C.sub.1-6 alkyl or C.sub.1-6 alkoxy group, or a halogen or hydrogen atom are useful in treating obesity and/or hyperglycaemia and/or inflammation in mammals.
式(II)的化合物:##STR1##或其药学上可接受的盐、较低的烷基或芳基酯或酰胺,其中R.sup.1和R.sup.2,可以相同也可以不同,分别是氢原子或甲基基团,n为1、2或3,Z为C.sub.1-6烷基或C.sub.1-6烷氧基,或卤素或氢原子,在治疗哺乳动物的肥胖和/或高血糖和/或炎症方面是有用的。